Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry